Literature DB >> 9010696

Calcium antagonist treatment and cardiovascular responses to a cold pressor test at high altitude.

E Hankø1, M Rostrup.   

Abstract

OBJECTIVE: We assessed the effects of the calcium antagonist felodipine on blood pressure, heart rate, oxygen saturation and cardiovascular responses to a cold pressor test at an altitude of 5200 m. Sixteen healthy climbers participated. A double-blind, placebo-controlled, randomized, crossover design was used. Placebo or felodipine were taken for 2 days and the treatment was changed after 3 days washout.
RESULTS: During felodipine treatment there were no significant changes in blood pressure (125/89 vs 127/86 mmHg), heart rate (82 vs 81 beats.min-1) or oxygen saturation (86% vs 86%). Moreover, there were no changes in the cardiovascular responses to the cold pressor test.
CONCLUSION: Felodipine is well tolerated at high altitude. It does not induce hypotension in normotensive men and does not affect cardiovascular reactivity to cold stress.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9010696     DOI: 10.1007/s002280050195

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  1 in total

1.  Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.

Authors:  J Minami; Y Kawano; Y Makino; H Matsuoka; S Takishita
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.